What is Arbor Research?
Arbor Research operates at the intersection of data science and public health, providing critical evidence-based solutions to policymakers, clinicians, and private sector stakeholders. By leveraging a multidisciplinary team of over 100 professionals, the company specializes in health policy analysis, clinical research, and the development of sophisticated health IT infrastructure. Their market position is defined by a commitment to rigorous methodology, which enables governmental and pharmaceutical partners to improve treatment effectiveness and navigate complex regulatory landscapes. Through the integration of modern technology and deep domain expertise, Arbor Research serves as a vital bridge between raw clinical data and actionable health policy, ultimately driving innovation in patient outcomes.
How much funding has Arbor Research raised?
Arbor Research has raised a total of $1M across 1 funding round:
Debt
$1M
Debt (2020): $1M with participation from PPP
Key Investors in Arbor Research
PPP
Public-Private Partnership
What's next for Arbor Research?
With this major enterprise-level funding, Arbor Research is poised to accelerate its technological roadmap and expand its footprint in the health innovation ecosystem. The strategic allocation of this capital will likely focus on enhancing the firm's proprietary data analytics platforms and scaling its research capabilities to meet the increasing demand for evidence-based decision-making tools. As the healthcare industry continues to prioritize digital transformation and data-driven policy, Arbor Research is well-positioned to leverage its recent financing to solidify its leadership, attract top-tier talent, and broaden its service offerings for both public and private sector partners. The firm's trajectory suggests a transition toward more integrated, large-scale health IT deployments that will define the next generation of clinical research and policy development.
See full Arbor Research company page
